hydroxyl radical has been researched along with alpha-tocopherol phosphate in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (alpha-tocopherol phosphate) | Trials (alpha-tocopherol phosphate) | Recent Studies (post-2010) (alpha-tocopherol phosphate) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 80 | 3 | 24 |
| Protein | Taxonomy | hydroxyl radical (IC50) | alpha-tocopherol phosphate (IC50) |
|---|---|---|---|
| Glutathione S-transferase omega-1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T | 1 |
1 other study(ies) available for hydroxyl radical and alpha-tocopherol phosphate
| Article | Year |
|---|---|
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides | 2007 |